Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa? MovDisord 22: 1-9

Author(s): Nutt JG

Abstract

Continuous dopaminergic stimulation (CDS) is a treatment strategy hypothesized to avoid or reduce the motor complications of long-term levodopa therapy, motor fluctuations, and dyskinesia, by preventing or reversing sensitization induced by pulsatile dopaminergic stimulation. The CDS hypothesis is itself based on several hypotheses. First, tonic dopaminergic stimulation is physiological. Second, sensitization is undesirable and should be reversed. Third, reduction of off time and dyskinesia can be induced simultaneously. Finally, clinical studies substantiate the CDS hypothesis. The evidence for these hypotheses is reviewed, and the need for randomized clinical trials that rigorously test the CDS hypothesis is emphasized.

Similar Articles

A survey of pain in idiopathic Parkinson's disease

Author(s): Lee MA, Walker RW, Hildreth TJ, Prentice WM

Depression and pain comorbidity: a literature review

Author(s): Bair MJ, Robinson RL, Katon W, Kroenke K

Pain is common in Parkinson's disease

Author(s): Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M

Low dopamine D(2) receptor binding potential in social phobia

Author(s): Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, et al.

Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients

Author(s): Erro R, Santangelo G, Picillo M, Vitale C, Amboni M, et al.

Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD--a comparison of neuropsychological effects

Author(s): Smeding HM, Esselink RA, Schmand B, Koning-Haanstra M, Nijhuis I, et al.

Pain in Parkinson's disease

Author(s): Ford B

CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice

Author(s): Airavaara M, Harvey BK, Voutilainen MH, Shen H, Chou J, et al.

Pain in Parkinson's disease

Author(s): Ha AD, Jankovic J

Pain sensitivity and clinical progression in Parkinson's disease

Author(s): Mylius V, Brebbermann J, Dohmann H, Engau I, Oertel WH, et al.

Validation of the non-motor symptoms questionnaire (NMS-Quest)

Author(s): Romenets SR, Wolfson C, Galatas C, Pelletier A, Altman R, et al.